Literature DB >> 9764331

The evolution of multiple drug resistance in malaria parasites.

M J Mackinnon1, I M Hastings.   

Abstract

Forces determining the rate of spread of drug resistance in malaria were explored using a genetics transmission model which took account of the strong population structure of these parasites. The rate of change of frequency of drug resistant mutants in the parasite population is primarily a function of the proportion of hosts treated with drugs, and parasite transmission rates. With high transmission rates, selection by drugs is more effective than with lower rates because the resistant mutant passes on more copies of itself to the next generation of hosts. Thus reducing transmission rates, either at the overall population level or from drug-treated individuals, should be effective in curbing the spread of resistance. An exception to this is when 2 unlinked genes act jointly (not independently) to confer resistance, when the prevailing transmission rate is already low, drug use is minimal, and resistance genes are rare. Reductions in fitness of the mutant in the absence of drugs (i.e., a fitness cost to resistance) and the degree of epistasis and the mode of gene action of the drugs do not alter these conclusions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764331     DOI: 10.1016/s0035-9203(98)90745-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  35 in total

1.  Antimalarial drugs clear resistant parasites from partially immune hosts.

Authors:  P Cravo; R Culleton; P Hunt; D Walliker; M J Mackinnon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.

Authors:  Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2003-09       Impact factor: 2.345

Review 3.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

4.  The effect of host heterogeneity and parasite intragenomic interactions on parasite population structure.

Authors:  Ruth Hamilton; Mike Boots; Steve Paterson
Journal:  Proc Biol Sci       Date:  2005-08-22       Impact factor: 5.349

5.  Benefits of using multiple first-line therapies against malaria.

Authors:  Maciej F Boni; David L Smith; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

6.  The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.

Authors:  S Huijben; D G Sim; W A Nelson; A F Read
Journal:  J Evol Biol       Date:  2011-08-23       Impact factor: 2.411

7.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

8.  Inbreeding in stochastic subdivided mating systems: the genetic consequences of host spatial structure, aggregated transmission dynamics and life history characteristics in parasite populations.

Authors:  Guha Dharmarajan
Journal:  J Genet       Date:  2015-03       Impact factor: 1.166

9.  Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.

Authors:  Allen L Malisa; Richard J Pearce; Salim Abdulla; Hassan Mshinda; Patrick S Kachur; Peter Bloland; Cally Roper
Journal:  Malar J       Date:  2010-07-05       Impact factor: 2.979

10.  Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country.

Authors:  Tepanata Pumpaibool; Céline Arnathau; Patrick Durand; Naowarat Kanchanakhan; Napaporn Siripoon; Aree Suegorn; Chitr Sitthi-Amorn; François Renaud; Pongchai Harnyuttanakorn
Journal:  Malar J       Date:  2009-07-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.